Communicable Disease Control and Health Protection Handbook
John Wiley & Sons Inc (Verlag)
9781394327690 (ISBN)
- Noch nicht erschienen (ca. März 2026)
- Versandkostenfrei
- Auch auf Rechnung
- Artikel merken
Communicable Disease Control and Health Protection Handbook provides practical advice for specific situations and the important background knowledge that underlies communicable disease control activities. The book, designed to be concise and accessible, explains topics ranging from basic principles to recent changes and innovations in health protection practice. Major syndromes and individual infections are insightfully addressed, as well as an outline of the World Health Organization's international health regulations and the organizational arrangements in place in all European Union nations. This Fifth Edition has been thoroughly revised to capture new developments in the area, especially those following the COVID-19 pandemic.
Communicable Disease Control and Health Protection Handbook includes information on:
Meningitis and meningism, gastrointestinal infection, community acquired pneumonia, rash in pregnancy, rash and fever in children, and illness in returning travelers
Amoebic dysentery, anthrax, botulism, chickenpox and shingles, chlamydia trachomatis, and cholera
Managing incidents and outbreaks, community infection control, hospital infection control, antimicrobial stewardship, and risks to and from healthcare workers
Prevention of blood-borne infections, migrant and refugee health, managing acute chemical and radiation incidents, and global health security
Communicable Disease Control and Health Protection Handbook is an essential reference for public health professionals working in communicable disease control and health protection, public health physicians, epidemiologists, public health nurses, infection control nurses, environmental health officers, microbiologists, policy makers, and general practitioners.
Professor Karl Ekdahl is the CEO for ’Prosanis Sverige AB’ and Medical Director for ’Reserådet’, Sweden’s largest Internet portal on vaccines and travel medicine. Professor Ralf Reintjes is a Full Professor for Epidemiology and Public Health Surveillance in Hamburg, Germany and Adjunct Professor for Infectious Disease Epidemiology in Tampere, Finland. Dr. Obaghe Edeghere is the Deputy Director for the Field Services division at the UK Health Security Agency. Dr. Norman Begg is a vaccine consultant who acts as a regular advisor to the World Health Organization.
About the Authors
Foreword (to be added, possibly by ECDC Director)
List of Abbreviations (yet to come)
Section A: Basic concepts
A.1 How to use this book
A.2. Basic concepts in the epidemiology and control of infectious disease
A.3 Basic concepts in the prevention of infection
A.4 Emergency risk communication
A.5 Health protection on‐call
Section B: Syndromes
B.1 Meningitis and meningism
B.2 Gastrointestinal infection
B.3 Community acquired pneumonia
B.4 Rash in pregnancy
B.5 Rash and fever in children
B.6 Illness in returning travellers
B.7 Jaundice
B.8 Infection in the immunosuppressed
Section C: Diseases
C.1 Amoebic dysentery
C.2 Anthrax
C.3 Bacillus cereus
C.4 Botulism
C.5 Brucellosis
C.6 Campylobacter
C.7 Chickenpox and shingles (varicella-zoster infections)
C.8 Chickungunya
C.9 Chlamydophila pneumoniae
C.10 Chlamydia trachomatis
C.11 Cholera
C.12 CJD and other human transmissible spongiform encep
C13 Clostridioides difficile
C14 Clostridium perfringens
C15 Corona viruses excluding Covid-19
C16 COVID-19
C17 Cryptosporidiosis
C18 Cyclosporiasis
C19 Cytomegalovirus
C20 Dengue fever
C21 Diphtheria
C.22 Enterococci, including Glycopeptide-resistant enterococci (GRE)
C23 Enterovirus infections, including hand, foot and mouth disease
C24 Epstein-Barr virus
C25 Giardiasis
C.26 Gram negative bacteraemia (including Carbapenem-resistant enterobacterales)
C.27 Gonorrhoea, syphilis and other acute STIs
C28 Hantavirus
C29 Headlice
C30 Helicobacter pylori
C31 Hepatitis A
C32. Hepatitis B
C33 Hepatitis C
C34 Delta Hepatitis
C35 Hepatitis E
C36 Herpes simplex
C37 Haemophilus influenzae type b
C38 HIV and AIDS
C39 Influenza
C40 Japanese B encephalitis
C41 Legionellosis
C42 Leprosy
C43 Leptospirosis
C44 Listeriosis
C45 Lyme disease (Borreliosis)
C46 Malaria
C47 Measles
C48 Meningococcal infection
C49 MRSA (Meticillin-resistant Staphylococcus aureus)
C50 Mumps
C51 Mycoplasma pneumoniae
C52 Norovirus
C53 Paratyphoid fever
C54 Parvovirus B19 (Fifth disease)
C55 Plague
C56 Pneumococcal infection
C57 Poliomyelitis
C58 Psittacosis
C59 Q fever
C60 Rabies
C61 Relapsing fever
C62 Respiratory syncytial virus (RSV)
C63 Ringworm
C64 Rotavirus
C65 Rubella
C66 Salmonellosis
C67 Scabies
C68 Schistosomiasis
C69 Shigellosis
C.70 Shiga toxin‐producing Escherichia coli (STEC) and other diarrhoeagenic E. coli
C71 Smallpox/Mpox
C72 Staphylococcal food poisoning
C73 Streptococcal infections
C74Tetanus
C75 Threadworms
C76 Tick-borne encephalitis
C77 Toxocara
C78 Toxoplasmosis
C79 Tuberculosis (and other Mycobacteria)
C80 Tularaemia
C81Typhoid fever
C82 Vibrio parahaemolyticus
C83Viral haemorrhagic fevers, including Ebola
C84 Warts and verrucae
C85 West Nile virus
C86 Whooping cough
C87 Yellow fever
C88 Yersiniosis
C89 Zika virus
C90 Rare diseases:
C90.1 - Bacteria
C90.2 Rickettsia, including typhus and ehrlichia
C90.3 Viruses
C90.4 Protozoa
C90.5 Helminths
C90.6 Fungi
C90.7 Bites, stings + venoms
C90.8 Chemical food-borne illness
Section D: Health protection services and functions
D01 Surveillance of Comm Dis
D02 Managing Incidents and Outbreaks
D03 Community Infection Control
D04 Hospital Infection Control
D05 Antimicrobial stewardship
D06 Risks to & from from healthcare workers
D07 Immunisation services
D08 Co‐ordination of sexual health services
D09 Prevention of blood-borne infections
D10 Services for TB control
D11 Travel Health
D12 Migrant + refugee health
D13 Emergency Preparedness Planning + Response
D14 Non-infectious environmental hazards
D15 Managing acute chemical incidents
D16 Managing acute radiation incidents
D17 Deliberate release of biological/chem/rad
D18 Clinical governance and audit
D19 Global health security
Setion E: Organisational arrangements
E01 WHO+ International Health Regulations
E02 International collaboration in Europe
E03 Detailed national example - England
E04 Austria
E05 Belguim
E06 Bulgaria
E07 Croatia
E08 Cyprus
E09 Czech Rep
E10 Denmark
E11 Estonia
E12 Finland
E13 France
E14 Germany
E15 Greece
E16 Hungary
E17 Iceland
E18 Republic of Ireland
E19 Italy
E20 Latvia
E21 Lithuania
E22 Luxemburg
E23 Malta
E24 The Netherlands
E25 Norway
E26 Poland
E27 Portugal
E28 Romania
E29 Slovakia
E30 Slovenia
E31 Spain
E32 Sweden
E33 Switzerland
E34 United Kingdom
Sec 6: Useful information
Appendix 1. Addresses and phones (To be updated closer to the publishing)
Appendix 2. Guidance documents (To be updated closer to the publishing)
Appendix 3. European national centre websites (To be updated closer to the publishing)
Appendix 4. Useful general websites (To be updated closer to the publishing)
| Erscheint lt. Verlag | 5.3.2026 |
|---|---|
| Verlagsort | New York |
| Sprache | englisch |
| Themenwelt | Medizin / Pharmazie ► Allgemeines / Lexika |
| Studium ► Querschnittsbereiche ► Infektiologie / Immunologie | |
| ISBN-13 | 9781394327690 / 9781394327690 |
| Zustand | Neuware |
| Informationen gemäß Produktsicherheitsverordnung (GPSR) | |
| Haben Sie eine Frage zum Produkt? |
aus dem Bereich
